JP MORGAN/CALL/ELI LILLY & CO/740/0.01/17.01.25 | Market Closed - Börse Stuttgart 02:16:17 14/06/2024 pm IST | ||
| 1.8 EUR | +9.09% |
|
| Current month | +36.36% | ||
| 1 month | +89.47% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 1.8 | +9.09% |
| 13/24/13 | 1.65 | -1.20% |
| 12/24/12 | 1.67 | -8.74% |
| 11/24/11 | 1.83 | +16.56% |
| 10/24/10 | 1.57 | +9.79% |
Delayed Quote Börse Stuttgart
Last update June 14, 2024 at 02:16 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | J.P. Morgan |
| WKN | JK27UW |
| ISIN | DE000JK27UW0 |
| Date issued | 08/02/2024 |
| Strike | 740 $ |
| Maturity | 17/01/2025 (216 Days) |
| Parity | 100 : 1 |
| Emission price | 0.76 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.83 € |
|---|---|
| Lowest since issue | 0.82 € |
| Delta | 0.81x |
| Omega | 3.853 |
| Premium | 5.38x |
| Gearing | 4.73x |
| Moneyness | 1.187 |
| Difference Strike | -138.5 $ |
| Difference Strike % | -18.71% |
| Spread | 0.01 € |
| Spread % | 0.57% |
| Theoretical value | 1.735 |
| Implied Volatility | 33.78 % |
| Total Loss Probability | 25.99 % |
| Intrinsic value | 1.293 |
| Present value | 0.4417 |
| Break even | 925.73 € |
| Theta | -0.01x |
| Vega | 0.02x |
| Rho | 0.03x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4
USD
Average target price
855.4
USD
Spread / Average Target
-2.63%
- Stock Market
- Warrants
- Warrant
